Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy.
Bergh J, Norberg T, Sjögren S, Lindgren A, Holmberg L. Bergh J, et al. Among authors: norberg t. Nat Med. 1995 Oct;1(10):1029-34. doi: 10.1038/nm1095-1029. Nat Med. 1995. PMID: 7489358
Sequencing of the tumor suppressor gene TP 53.
Linderholm B, Norberg T, Bergh J. Linderholm B, et al. Among authors: norberg t. Methods Mol Med. 2006;120:389-401. doi: 10.1385/1-59259-969-9:389. Methods Mol Med. 2006. PMID: 16491613
Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.
Lindahl T, Landberg G, Ahlgren J, Nordgren H, Norberg T, Klaar S, Holmberg L, Bergh J. Lindahl T, et al. Among authors: norberg t. Carcinogenesis. 2004 Mar;25(3):375-80. doi: 10.1093/carcin/bgh019. Epub 2003 Nov 21. Carcinogenesis. 2004. PMID: 14633656
Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
Smeds J, Wärnberg F, Norberg T, Nordgren H, Holmberg L, Bergh J. Smeds J, et al. Among authors: norberg t. Acta Oncol. 2005;44(1):41-9. doi: 10.1080/02841860410002842. Acta Oncol. 2005. PMID: 15848905
Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys-His domain.
Karlsson O, Thor S, Norberg T, Ohlsson H, Edlund T. Karlsson O, et al. Among authors: norberg t. Nature. 1990 Apr 26;344(6269):879-82. doi: 10.1038/344879a0. Nature. 1990. PMID: 1691825
Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets.
Williams C, Norberg T, Ahmadian A, Pontén F, Bergh J, Inganäs M, Lundeberg J, Uhlén M. Williams C, et al. Among authors: norberg t. Clin Chem. 1998 Mar;44(3):455-62. Clin Chem. 1998. PMID: 9510848
Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort.
Norberg T, Klaar S, Kärf G, Nordgren H, Holmberg L, Bergh J. Norberg T, et al. Cancer Res. 2001 Nov 15;61(22):8317-21. Cancer Res. 2001. PMID: 11719465
Enzymatic mutation detection method evaluated for detection of p53 mutations in cDNA from breast cancers.
Norberg T, Klaar S, Lindqvist L, Lindahl T, Ahlgren J, Bergh J. Norberg T, et al. Clin Chem. 2001 May;47(5):821-8. Clin Chem. 2001. PMID: 11325884
Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors.
Norberg T, Lennerstrand J, Inganäs M, Bergh J. Norberg T, et al. Int J Cancer. 1998 Aug 21;79(4):376-83. doi: 10.1002/(sici)1097-0215(19980821)79:4<376::aid-ijc12>3.0.co;2-3. Int J Cancer. 1998. PMID: 9699530
Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53.
Norberg T, Jansson T, Sjøgren S, Mårtensson C, Andréasson I, Fjällskog ML, Lindman H, Nordgren H, Lindgren A, Holmberg L, Bergh J. Norberg T, et al. Acta Oncol. 1996;35 Suppl 5:96-102. doi: 10.3109/02841869609083980. Acta Oncol. 1996. PMID: 9142977 Review.
74 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback